Alimera Sciences Articles
News briefs from Alimera on Iluvien and Xencor on Xtend; Galapagos milestone and acquisition
17 January 2013
News briefs from Genmab/Kyowa Hakko; Alimera/Quintiles; Novo Nordisk; Astellas; Sandoz
5 December 2012
NICE rejects Alimera's Iluvien for DMO in draft guidance
8 August 2012
Alimera's Iluvien approved in Portugal
6 June 2012
Another FDA rejection for Alimera’s DME drug Iluvien
14 November 2011
US FDA approves Novartis’ Amturnide for BP and Watson’s chewable oral contraceptive, but delays Alimera’s Iluvien
24 December 2010
Showing 1-9 of 9 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
